IP Library Patent Application 12990486
Patent Application
App. No. 12/990,486

Analogs of Propofol, Preparation Thereof and Use as Anesthetics

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/990,486
Abstract

Compounds of formula (I) wherein X is H or F and pharmaceutically acceptable salts thereof are useful as anesthetics.

Claims (20)

1 . A compound of formula (I):

wherein X is H or F; or a pharmaceutically acceptable salt thereof.

2 . A compound as claimed in claim 1 , wherein X is H.

3 . A pharmaceutical composition comprising a compound as claimed in claim 1 , and a pharmaceutically acceptable carrier.

4 . The pharmaceutical composition of claim 3 which is formulated for intravenous administration.

5 . The pharmaceutical composition of claim 4 which is formulated as a lipid emulsion.

6 . A method for inducing or maintaining general anesthesia in an animal comprising administering to the animal an effective amount of a compound as claimed in claim 1 .

7 . A method for promoting sedation in an animal comprising administering to the animal an effective amount of a compound as claimed in claim 1 .

8 - 10 . (canceled)

11 . A process for the preparation of a compound as defined in claim 1 , which comprises reducing a compound of general formula (II)

in which X is H or F, or a salt thereof, followed optionally by forming a pharmaceutically acceptable salt.

12 . A pharmaceutical composition comprising a compound as claimed in claim 2 , and a pharmaceutically acceptable carrier.

13 . The pharmaceutical composition of claim 12 which is formulated for intravenous administration.

14 . The pharmaceutical composition of claim 13 which is formulated as a lipid emulsion.

15 . A process for the preparation of a compound as defined in claim 2 , which comprises reducing a compound of general formula (II)

or a salt thereof, followed optionally by forming a pharmaceutically acceptable salt.

16 . The method of claim 6 , wherein X is H.

17 . The method of claim 7 , wherein X is H.

18 . The process of claim 11 , wherein the process comprises forming a pharmaceutical acceptable salt.

19 . The process of claim 15 , wherein the process comprises forming a pharmaceutical acceptable salt.

Assignments (2)
CHANGE OF NAME Recorded May 9, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028185/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2010
From: JENKINS, THOMAS E.
To: PHARMACOFORE, INC.
Reel/Frame 025323/0253 →